Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Diabetes News and Research
Diabetes News
Statins reduce risk of cancer says Daily Mail
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="Cowboyjim" data-source="post: 326695" data-attributes="member: 23128"><p>The DM hah hah... mind you there seems to be a super statin in the pipeline if this is anything to go by</p><p></p><p><a href="http://www.nytimes.com/2012/11/06/business/new-drugs-for-lipids-set-off-race.html?_r=0" target="_blank">http://www.nytimes.com/2012/11/06/business/new-drugs-for-lipids-set-off-race.html?_r=0</a></p><p></p><p>Dr. Evan A. Stein of the Metabolic and Atherosclerosis Research Center in Cincinnati, said that about <u>10 to 20 percent of patients could not tolerate statins at all</u>, or at least could not tolerate doses high enough to lower cholesterol sufficiently. Their main alternative now is Merck’s Zetia, which reduces cholesterol about 18 percent.</p><p></p><p>Dr. Stein, who is a consultant to Amgen, presented the results on Monday of a trial of Amgen’s drug, AMG 145, in such patients.</p></blockquote><p></p>
[QUOTE="Cowboyjim, post: 326695, member: 23128"] The DM hah hah... mind you there seems to be a super statin in the pipeline if this is anything to go by [url]http://www.nytimes.com/2012/11/06/business/new-drugs-for-lipids-set-off-race.html?_r=0[/url] Dr. Evan A. Stein of the Metabolic and Atherosclerosis Research Center in Cincinnati, said that about [u]10 to 20 percent of patients could not tolerate statins at all[/u], or at least could not tolerate doses high enough to lower cholesterol sufficiently. Their main alternative now is Merck’s Zetia, which reduces cholesterol about 18 percent. Dr. Stein, who is a consultant to Amgen, presented the results on Monday of a trial of Amgen’s drug, AMG 145, in such patients. [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes News and Research
Diabetes News
Statins reduce risk of cancer says Daily Mail
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…